Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.21.1
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 790,847 1,650,511
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 118,388 338,595
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 672,459 1,311,916